Why Insomnia and Addiction Feed Each Other in Recovery

Insomnia and addiction are clinically linked conditions, each making the other harder to treat. Substances disrupt the brain's sleep architecture over months or years, producing fragmented, unrestorative rest. When a person stops using, the brain has lost its ability to sleep naturally, leaving them exhausted at exactly the moment recovery demands the most. That exhaustion then drives cravings, sharpens anxiety, and erodes the motivation to stay in treatment.

The relationship runs both ways. People arriving with co-occurring anxiety and addiction often find that disrupted sleep is the most destabilising part of early treatment, and NIAAA's overview of alcohol's effects on the body documents how heavy substance use reshapes the neurological systems that govern rest. Sleep problems raise the risk of relapse, and relapse worsens sleep. At Jintara, insomnia is treated not as a side complaint but as a condition that, left unmanaged, undermines every other clinical intervention on the program.

Alcohol, benzodiazepines and prescription sleeping pills all trade short-term sedation for the sleep quality they cannot restore. Alcohol shortens the time it takes to fall asleep, but it suppresses REM sleep and causes frequent waking in the second half of the night. People who drink heavily often believe alcohol helps them sleep, not realising that the alcohol itself is what keeps them waking in the early hours.

Benzodiazepines and Z-drugs, the prescription sleeping pills such as zolpidem, follow the same pattern of sedation without restorative sleep, then rebound insomnia when the dose wears off. Sleeping pill addiction is now one of the more common presentations at Jintara, often alongside alcohol, and long-term use creates a dependency in which the brain stops producing its own sleep signals. SAMHSA clinical guidance on sedative and alcohol co-dependence sets out how this combined withdrawal is managed. Detoxing from both substances calls for a carefully managed taper that addresses the physical withdrawal and the sleep disruption that follows it.

Stimulants including cocaine, methamphetamine and MDMA work against sleep by holding the brain in a state of arousal, elevating dopamine and noradrenaline. During active use, sleep is often reduced to two to four hours a night. When stimulant use stops, the brain swings the other way, into a stretch of hypersomnia, sleeping twelve or more hours, followed by weeks of fragmented sleep as dopamine pathways try to normalise.

This extended disruption is easily misread as a sign that something is wrong with the person, when it is a predictable stage of neurological recovery. The link between stimulant withdrawal and depression and addiction is well established, because the low mood and loss of pleasure in the weeks after stimulant cessation are driven by the same dopamine disruption that causes the insomnia. NIDA's research on methamphetamine describes these neurological effects in detail. Jintara's program plans for this timeline, setting realistic expectations about when sleep will stabilise.

Early recovery insomnia is a predictable neurological process, not a sign that treatment is failing. Lying awake through the first week is one of the most common and most destabilising experiences for people entering treatment, and it reliably produces the fear that something has gone wrong. It has not.

Denise O'Leary, Jintara's Clinical Director, treats sleep restoration as the first stabilisation target in week one, and notes that most clients arrive with completely dysregulated sleep. Understanding what the first week involves at Jintara helps clients and families set realistic expectations. The clinical goal for week one is not perfect sleep but functional sleep, defined as enough rest to take part in groups and therapy the next day. Even three to four hours is an acceptable starting point while the brain relearns how to rest without chemical help.

Sleep restoration at Jintara is multimodal, using several interventions at once rather than relying on any single solution. The nursing team runs a dedicated insomnia assessment protocol to find the root cause of each person's sleep difficulty before choosing an intervention. Lertkhwan Sukpia, Jintara's Medical Team Lead, describes the sequence, that nursing first confirms all medical and withdrawal medications are in place, then works with the therapy and fitness teams to adjust daytime activity so a person arrives at bedtime physically ready to rest.

Sleep is handled inside the wider treatment rather than in isolation. The cognitive side of it, including the performance anxiety that builds up around sleeping itself, is addressed in individual therapy as part of the integrated treatment program, and these cognitive and behavioural methods for insomnia are well validated for recovery populations. A facility-wide 10pm curfew shifts the whole environment into night mode, with nurses on rounds to support anyone still awake. The aim is to rebuild sleep as a system, not to suppress a symptom.

Jintara does not use benzodiazepines or Z-drugs to manage insomnia during treatment, because introducing a sedative dependency to treat a sedative withdrawal would be clinically counterproductive. The clinical team draws on non-addictive options instead, and the overlap between sleep disorders and mood disorders shapes how they are chosen.

That overlap matters most where a mood disorder is involved. Where insomnia co-occurs with bipolar disorder and addiction, the medication review is led by the treating psychiatrist rather than handled on its own. That psychiatrist tracks the relationship between mood stabilisation and sleep quality across the whole stay.

A 24-hour nursing presence is one of the most tangible forms of sleep support at Jintara. Nurses conduct night rounds, checking on clients, encouraging anyone still awake to rest, and offering calm support to those experiencing anxiety or distress. When a person is convinced they will never sleep again, Lertkhwan Sukpia describes a direct, factual response, reminding the client of the evidence from the past few nights and inviting them to try a different approach.

The team also manages access to phones and devices after 10pm, gently encouraging clients to leave a phone with the nurse overnight where device use is disrupting sleep, and sound relaxation tracks are available for those who find them helpful. The regulation skills a person builds through these nights feed directly into their aftercare planning, so the work does not stop at discharge. Nurses do not wait until morning to escalate, and where someone stays severely sleep-deprived after several days and does not respond to other measures, the case is referred back to the psychiatrist for medication review.

Improved sleep is measurable within the first two weeks of treatment for most clients at Jintara. The typical trajectory is recognisable, a difficult first three to five days, sleep improving to five or six hours by the end of week one, and most clients sleeping seven hours or more by week two. Full normalisation of sleep architecture takes longer, often two to three months after discharge, as the brain continues to rebalance.

Sleep quality is one of the clinical indicators Jintara tracks throughout treatment, alongside mood, appetite, engagement in groups, and medication response. When sleep improves, so does cognitive clarity, emotional regulation, and the capacity to engage with therapy. For people presenting with co-occurring ADHD and addiction, disrupted sleep is often a shared pathway, and the two conditions are managed together within the dual diagnosis assessment. That gradual repair is well documented, and NIDA's overview of treatment and recovery describes how the brain keeps healing for months into recovery. Recovery from insomnia is not a byproduct of addiction treatment at Jintara. It is a target.